Robert C. Doebele, MD, PhD, associate professor, Division of Medical Oncology, University of Colorado, discusses brain metastases in ROS1-positive non-small cell lung cancer.
Robert C. Doebele, MD, PhD
Advertisement
Articles by Robert C. Doebele, MD, PhD
Robert C. Doebele, MD, PhD, associate professor, Division of Medical Oncology, University of Colorado, discusses the significance of the results of a trial exploring entrectinib in patients with ROS1-positive non
Advertisement
Latest Updated Articles
Dr. Doebele Discusses Brain Metastases in ROS1+ NSCLCPublished: October 31st 2017 | Updated:
Dr. Doebele on Significant Findings of Entrectinib in Patients With ROS1+ NSCLCPublished: October 19th 2017 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
Nuvisertib Yields Strong Safety, Promising Efficacy in R/R Myelofibrosis
5